A health economics evaluation assists companies during product development to better understand the product’s impact across the ecosystem and position it appropriately.
Health Economics Evaluation and Value Proposition for an Antimicrobial Medical Device in the U.S. Market
Alira Health’s Transformation Talks: Early Access Programs: Why and How?
Listen to this episode of "Transformation Talks" to discover the benefits and challenges of implementing EAPs from both the industry and payer perspectives and the main recommendations(...)
Your Favorite Alira Health Publications from 2021
As 2021 ends, take a look at Alira Health most popular publications about this year’s main healthcare trends.
Alira Health’s Transformation Talks: Navigating the Vaccines’ Renaissance
Tune into this episode of "Transformation Talks" to learn more about the the ups and downs of the vaccine industry, how the COVID pandemic has transformed it, and what is coming up next.
Leveraging Data Intelligence for Effective Opportunity Screening and Prioritization in Drug Discovery
Our biotech client needed an innovative, effective way to identify which binding sites and therapeutic indications they should target for the development of new therapeutic agents for(...)
White Paper: Enhancing Patient Access with Early Access Programs
Pharmaceutical companies are facing an increasing demand from physicians for Early Access Programs (EAPs) and are willing to make their innovative medicines available to patients with(...)
Event: ISPOR Europe 2021
Join Alira Health experts at virtual ISPOR.
Webinar: The Women Healthcare Revolution: The Israeli Perspective
Alira Health's David Uffer, Senior Partner and VP, MedTech will moderate the webinar The Women Healthcare Revolution: The Israeli Perspective on December 1st.